Exemple de utilizare a Study demonstrated în Engleză și traducerile lor în Română
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
-
Programming
This study demonstrated affinities between the skull morphology of Ar.
Children in this study demonstrated ACR Ped 30, 50, 70, and 90 responses as early as week 4.
This study demonstrated the correlation between environmental mercury and autism rates in Texas.
Another 2004 study demonstrated that insulin also increases the response of HGH to GHRP-6.
This study demonstrated the efficacy of INVEGA of the medium dose group in adolescent subjects with schizophrenia.
This study demonstrated that laser combs are more effective in reversing hair loss as compared to conventional treatment.
The study demonstrated that the post-treatment recovery in growth at 2 years post-treatment was maintained to 6 years post-treatment.
Interestingly, one study demonstrated an increased prevalence of abnormally low thyroid hormone levels(hypothyroidism) in patients with gout.
This study demonstrated that penis straighteners are more effective in correction of penile curvature as compared to conventional treatment.
This study demonstrated that penis straightening devices are more effective in reversing penile curvature as compared to conventional treatment.
This study demonstrated an improvement in cognitive and psychomotor performance in healthy volunteers receiving ashwagandha root extract capsules.
The study demonstrated improvements in sleep latency, quality of sleep and morning alertness, with no withdrawal symptoms and rebound insomnia.
A study demonstrated the deodorizing action of green tea polyphenols in a test against methyl mercaptan, the compound most closely associated with halitosis.
In addition, the study demonstrated indirectly the same lung deposition with a trend to a deeper lung deposition based on a higher ratio in Cmax and a shorter Tmax.
The study demonstrated that safety and immunogenicity were generally comparable with observations made in studies of intramuscular administration.
Data from this study demonstrated a significant advantage for intravenous Bondronat 6 mg over placebo in the reduction in SREs measured by the time-adjusted SMPR(p=0.004).
The study demonstrated that alogliptin did not increase the risk of having a MACE compared to placebo[Hazard Ratio: 0.96; 1-sided 99% Confidence Interval: 0-1.16].
This study demonstrated that bodyweight was the predominant covariate to explain the busulfan pharmacokinetic variability in children over body surface area or age.
The study demonstrated that this would lead to a significant increase in transport costs resulting in a modal shift from rail to road of the order of magnitude of 0.4% of total rail freight demand.
The study demonstrated that companies that have a strategic approach to multilingual communication are able to boost their export sales by more than 40% compared to their competitors without formal language strategies.
While this study demonstrated that paediatric patients require a higher palonosetron dose than adults to prevent chemotherapy-induced nausea and vomiting, the safety profile is consistent with the established profile in adults(see section 4.8).
The study demonstrated that foetuses exposed in utero to the combination sustained a higher level of nucleoside analogue-DNA incorporation into multiple foetal organs, and showed evidence of more telomere shortening than in those exposed to zidovudine alone.
The study demonstrated that foetuses exposed in utero to the combination sustained a higher level of nucleoside analogue-DNA incorporation into multiple foetal organs, and showed evidence of more telomere shortening than in those exposed to zidovudine alone.
The study demonstrated that foetuses exposed in utero to the combination sustained a higher level of nucleoside analogue- DNA incorporation into multiple foetal organs, and showed evidence of more telomere shortening than in those exposed to zidovudine alone.
The study demonstrated a clinically and statistically significant relative risk reduction of 18% in the rate of the primary composite endpoint of cardiovascular mortality and hospitalisation for worsening heart failure(hazard ratio: 0.82, 95%CI[0.75;0.90]- p< 0.0001) apparent within 3 months of initiation of treatment.
The study demonstrated that treatment with Cinryze within 4 hours after the onset of an HAE attack resulted in a greater than 2-fold decrease in the time to beginning of unequivocal relief of the defining symptom of the HAE attack compared to placebo(median 2 hours for Cinryze vs.> 4 hours for placebo, p=0.048).
The 3 studies demonstrated similar survival rates.
Numerous studies demonstrate this.
Those studies demonstrate that.
The studies demonstrate that children living without their parents-.